ConductScience.org, home

Paper36044544

2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease.

García-Cárceles J and 14 others. J Med Chem, 2022. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. 2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease. Papers, record 36044544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36044544

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease.
PubMed
Journal
J Med Chem
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2026-01-27
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1García-Cárceles JJavierhttps://orcid.org/0000-0003-4614-9639
2Vázquez-Villa HHenarhttps://orcid.org/0000-0001-7911-3160
3Brea JJoséhttps://orcid.org/0000-0002-5523-1979
4Ladron de Guevara-Miranda DDavid
5Cincilla GGiovannihttps://orcid.org/0000-0002-5242-0707
6Sánchez-Martínez MMelchorhttps://orcid.org/0000-0002-3674-8577
7Sánchez-Merino AAnabel
8Algar SSergiohttps://orcid.org/0000-0003-0933-5985
9Teresa de Los Frailes MMaría
10Roberts RSRichard S
11Ballesteros JAJuan A
12Rodríguez de Fonseca FFernando
13Benhamú BBellindahttps://orcid.org/0000-0002-0864-026X
14Loza MIMaría Ihttps://orcid.org/0000-0003-4730-0863
15López-Rodríguez MLMaría Lhttps://orcid.org/0000-0001-8607-1085

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CocaineMajor topic
Parkinson DiseaseMajor topic
Animals
Biphenyl Compounds
Dopamine
Dopamine Agents
Dopamine Agonists
Humans
Indazoles
Levodopa
Ligands
Mice
Nitrofurans
Receptors, Dopamine
Receptors, Dopamine D1

Source PubMed

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115,116,359Development and testing of a general amber force field.J Comput Chem2004https://conductscience.org/library/papers/15116359PubMed
227,900,648Etelcalcetide: First Global Approval.Drugs2016https://conductscience.org/library/papers/27900648PubMed
325,176,435Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.Nat Rev Drug Discov2014https://conductscience.org/library/papers/25176435PubMed
422,148,748Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.J Med Chem2012https://conductscience.org/library/papers/22148748PubMed
525,076,876Distinct motor impairments of dopamine D1 and D2 receptor knockout mice revealed by three types of motor behavior.Front Integr Neurosci2014https://conductscience.org/library/papers/25076876PubMed
616,229,044Vanadium-catalyzed sulfur oxidation/kinetic resolution in the synthesis of enantiomerically pure alkyl aryl sulfoxides.Angew Chem Int Ed Engl2005https://conductscience.org/library/papers/16229044PubMed
729,075,003Trends in GPCR drug discovery: new agents, targets and indications.Nat Rev Drug Discov2017https://conductscience.org/library/papers/29075003PubMed
823,398,684Regulation of G protein-coupled receptors by allosteric ligands.ACS Chem Neurosci2013https://conductscience.org/library/papers/23398684PubMed
915,742,468Investigations on the iron-catalyzed asymmetric sulfide oxidation.Chemistry2005https://conductscience.org/library/papers/15742468PubMed
1021,548,569Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-Adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid.J Med Chem2011https://conductscience.org/library/papers/21548569PubMed
1130,111,649Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor.Mol Pharmacol2018https://conductscience.org/library/papers/30111649PubMed
1228,280,503New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease.Front Biol (Beijing)2015https://conductscience.org/library/papers/28280503PubMed
1325,671,228Dopamine receptors - IUPHAR Review 13.Br J Pharmacol2015https://conductscience.org/library/papers/25671228PubMed
1423,319,549The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease.Pharmacol Rev2013https://conductscience.org/library/papers/23319549PubMed
1524,634,647Effects of acute versus repeated cocaine exposure on the expression of endocannabinoid signaling-related proteins in the mouse cerebellum.Front Integr Neurosci2014https://conductscience.org/library/papers/24634647PubMed
169,857,974Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.Mol Psychiatry1998https://conductscience.org/library/papers/9857974PubMed
1726,100,627Novel Allosteric Modulators of G Protein-coupled Receptors.J Biol Chem2015https://conductscience.org/library/papers/26100627PubMed
189,482,355Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.Arch Neurol1998https://conductscience.org/library/papers/9482355PubMed
1924,111,540Drugs for allosteric sites on receptors.Annu Rev Pharmacol Toxicol2014https://conductscience.org/library/papers/24111540PubMed
2027,148,592Allosteric Modulation of G Protein-Coupled Receptors: An Emerging Approach of Drug Discovery.Austin J Pharmacol Ther2014https://conductscience.org/library/papers/27148592PubMed

See all 63 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41,387,961Asymmetric synthesis of stereogenic-at-sulfur compounds via biocatalytic oxidation with Unspecific Peroxygenases.Nat Commun2025https://conductscience.org/library/papers/41387961PubMed
40,308,780Ginsenoside Rg1 in Parkinson's disease: from basic research to clinical applications.Front Pharmacol2025https://conductscience.org/library/papers/40308780PubMed
38,931,832Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?Pharmaceutics2024https://conductscience.org/library/papers/38931832PubMed
38,238,465Asymmetric synthesis of sulfoximines, sulfonimidoyl fluorides and sulfonimidamides enabled by an enantiopure bifunctional S(VI) reagent.Nat Chem2024https://conductscience.org/library/papers/38238465PubMed

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36044544

GET https://conductscience.org/api/papers/v1/36044544/references?page=2